Study on predictive biomarkers for the progression to cervical cancer from the aspect of genomic and epigenomic analysis, and the application of personalized intervention

Study on predictive biomarkers for the progression to cervical cancer from the aspect of genomic and epigenomic analysis, and the application of personalized intervention - Development and application of Biomarkers for CIN

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000020087

Enrollment

600

Registered

2015-12-06

Start date

2015-12-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical intraepithelial neoplasia(CIN)and cervical cancer

Interventions

None listed

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Patients who have the pathological diagnosis of CIN1 or CIN2

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
Progression to CIN3 or cervical cancer or regression to normal	—

Secondary

Measure	Time frame
Regression to the normal cervix Sustained CIN status Immune responses Genomic and epigenomic analysis	—

Countries

Japan

Contacts

Public ContactKei Kawana

The University of Tokyo Hospital Department of Obstetrics & Gynecology

kkawana-tky@umin.org03-3815-5411(ext33407)

Outcome results